Skip to content
sellWeak cluster of 410b5-1 plan

Eric Bjerkholt sold $469k of MIRM

CHIEF FINANCIAL OFFICER at Mirum Pharmaceuticals, Inc.. 5,000 shares at an average of $93.82, traded Jun 8, 2026, filed Jun 9, 2026.

Warning score
24
Value
$469k
5,000 shares
Holdings after
44,788
-10% from before
From 52-week low
+99%
low $47.05, close $93.58
From 52-week high
-16%
high $111.39, as of Jun 8, 2026

Score components

  • Role
    CFO
    +22
  • Trade size
    $469k at market
    +17
  • Share of holdings sold
    Sold 10% of holdings
    +5
  • Cluster
    4 insiders selling within 14 days
    +15
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

MIRMOct 12, 2026 · close 86.06
Since filing Jun 9, 2026: -9.9%SPY +6.1% · excess -16.0%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001197350-26-000007, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jun 8, 2026SOpen-market sale
Common Stock10b5-1
-2,258$92.84$210k47,530Jun 9, 2026
Jun 8, 2026SOpen-market sale
Common Stock10b5-1
-1,175$93.95$110k46,355Jun 9, 2026
Jun 8, 2026SOpen-market sale
Common Stock10b5-1
-1,567$95.12$149k44,788Jun 9, 2026
Jun 9, 2026MOption exercise
Common Stock10b5-1
+2,393$26.49$63k47,181Jun 9, 2026
Jun 9, 2026MOption exercise
Employee Stock Option (right to buy)derivative10b5-1
-2,393$0.00$026,653Jun 9, 2026

Related signals

Other insiders at Mirum Pharmaceuticals, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
52Moderate
MIRMsell 3
Mirum Pharmaceuticals, Inc.
Eric Bjerkholt
CHIEF FINANCIAL OFFICER
$978k
9,943 shares
-18%
38Weak
MIRMsell 310b5-1
Mirum Pharmaceuticals, Inc.
Jolanda Howe
SVP, GLOBAL CONTROLLER
$66k
658 shares
-52%
35Weak
MIRMsell 310b5-1
Mirum Pharmaceuticals, Inc.
Christopher Peetz
CHIEF EXECUTIVE OFFICER
$3.0M
30,000 shares
-13%
60Notable
MIRMsell 3
Mirum Pharmaceuticals, Inc.
Jolanda Howe
SVP, GLOBAL CONTROLLER
$4.0M
40,000 shares
-97%
41Moderate
MIRMsell 310b5-1
Mirum Pharmaceuticals, Inc.
Eric Bjerkholt
CHIEF FINANCIAL OFFICER
$600k
6,001 shares
-14%
30Weak
MIRMsell 310b5-1
Mirum Pharmaceuticals, Inc.
Christopher Peetz
CHIEF EXECUTIVE OFFICER
$2.0M
20,000 shares
-9%
42Moderate
MIRMsell 310b5-1
Mirum Pharmaceuticals, Inc.
Jolanda Howe
SVP, GLOBAL CONTROLLER
$194k
1,840 shares
-59%
42Moderate
MIRMsell 310b5-1
Mirum Pharmaceuticals, Inc.
Eric Bjerkholt
CHIEF FINANCIAL OFFICER
$611k
5,000 shares
-11%
30Weak
MIRMsell 310b5-1
Mirum Pharmaceuticals, Inc.
Christopher Peetz
CHIEF EXECUTIVE OFFICER
$2.4M
20,000 shares
-9%
35Weak
MIRMsell 310b5-1
Mirum Pharmaceuticals, Inc.
Jolanda Howe
SVP, GLOBAL CONTROLLER
$327k
2,721 shares
-47%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Eric Bjerkholt sold $469k of MIRM | InsiderTell